NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

My husband did not respond to the chemo. He had a resection of about 80% of the tumor (stage 4 glioblastoma), radiation for 6 weeks, temodar. with no success. He was given these treatments when he was diagnosedwith stage 3 anaplastic astrocytoma, and it progressed to stage 4. He then went through many rounds of Gleostine (CCNU), again, with no success. He is now on a clinical trial in which he gets infusions every few weeks, of Avastin (it only kills bad cells, unlike chemo), and this stabilized the tumor without chemo. He is now wearing the Optune Cap, along with doing the Avastin, and has gone from 5 partial seizures a day, to only one partial seizure since the Optune was put on six weeks ago, MRI on April 11, 2018, and crossing my fingers, but the oncologist believes with the dramatic decrease of seizures, the treatments, without the chemo, is working. He was diagnosed on my birthday... June 13, 2016, and is still here and fighting. This is after he beat Luekemia!!! He just turned 50, so he is young.
The goal of his oncologist, as of present, is to keep the tumor stable until the cutting edge clinical trials are approved by the FDA, which he believes are very near to happening. My husband recieves treatment at Cedars-Sinai, one of the top cancer facilities around. Believe me, his doctors have hope! We all need to hold on to the hope!


Diane Mar 23, 2018- 2:47 am
https://csn.cancer.org/comment/1621393#comment-1621393

"The goal of his oncologist, as of present, is to keep the tumor stable until the cutting edge clinical trials are approved by the FDA, which he believes are very near to happening."
Has someone any idea???

Cedars-Sinai

Keith L. Black, MD
Chair, Department of Neurosurgery
Ruth and Lawrence Harvey Chair in Neuroscience
Director, Maxine Dunitz Neurosurgical Institute
Professor, Neurosurgery
http://bio.csmc.edu/view/3453/Keith-L-Black.aspx?_ga=2.135426289.1959621335.1525969624-1137127903.1525367612

“I believe the next big thing in brain tumour research will focus on teaching the immune system how to eradicate tumours”
- Dr Keith L. Black, MD, chair and professor of Cedars-Sinai's Department of Neurosurgery.

http://www.curebraincancer.org.au/news/1047/teaching-our-immune-system-to-kill-glioblastoma-an-interview-with-dr-keith-l-black-

DCVax®-Brain and DC vaccines in the treatment of GBM
Christopher J Wheeler & Keith L Black
Pages 509-519 | Published online: 01 Apr 2009

“Conclusion: DC vaccine trials provide evidence of low toxicity in GBM patients and effective induction of antitumor immunity in the latest publications correlate with clinical improvements. Preliminary reports on DCVax-Brain clinical outcomes seem to follow these trends.”

https://www.tandfonline.com/doi/abs/10.1517/13543780902841951

Background
Dr. Keith L. Black, M.D. Co-Founded Imagine Pharmaceuticals Inc. and serves as its Lead Scientist. Dr. Black serves as Chairman of the Board and Chief Scientific Officer of Medlennium Technologies Inc. He is Co-Founder of NeuroVision Imaging LLC. He served on the University of California, Los Angeles faculty for 10 years where he was Professor of Neurosurgery. He served as the Head of the UCLA Comprehensive Brain Tumor Program. He is an internationally recognized neurosurgeon ...
https://www.bloomberg.com/research/stocks/private/person.asp?personId=9797868&privcapId=9794293